4th Quarter - Report

BALCH & BINGHAM, LLP for VAXIN PHARMACEUTICALS INC

Period 4th Quarter 2008 Filed Jan 13, 2009 Signed by James H. Hancock, Jr.-Partner

Official filing
Firm
BALCH & BINGHAM, LLP
Client
VAXIN PHARMACEUTICALS INC
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Funding for Immunocontraceptive vaccines through Department of Interior, Agriculture or Transportation Appropriations bills; in ovo vaccination by recombinant adenovirus vectors through Department of Agriculture or Homeland Security Appropriations bills; non-invasive vectored vaccine research through Department of Defense Authorization or Defense Appropriations bills.

LobbyistCovered position, as disclosed
MICHAEL J DAVIS Field Representative - Sen. Jeff Sessions
WILLIAM F STIERS Leg. Dir. - Reps. Wm. Dickinson and Terry Everett

Contacted: Transportation, Dept of (DOT); Interior, Dept of (DOI); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Navy, Dept of; SENATE; Health & Human Services, Dept of (HHS); Defense, Dept of (DOD); Homeland Security, Dept of (DHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.